Serum_lactate_dehydrogenase-3_isoenzyme_in_chronic_granulocytic_leukemia._Abnormal_levels_of_serum_lactate_dehydrogenase-3_(LD-3)_activity_were_observed_in_92%_of_patients_(35_of_38)_with_active_chronic_granulocytic_leukemia_(CGL),_in_40%_of_patients_(4_of_10)_in_partial_remission,_and_in_13%_of_patients_(1_of_8)_in_complete_remission._In_evaluating_the_electrophoretic_LD_isoenzyme_patterns_of_these_patients,_three_criteria_were_used._In_criterion-1_elevations,_the_LD-3/total_LD_ratio,_expressed_as_a_fraction_of_serum_total_LD,_and_LD-3_value,_expressed_in_absolute_units,_were_greater_than_the_upper_limit_of_the_reference_range._In_criterion-2_elevations,_only_the_LD-3/total_LD_ratio_was_greater_than_the_upper_limit_of_the_reference_range._In_criterion-3_elevations,_only_the_absolute_LD-3_activity_exceeded_the_upper_limit_of_the_reference_range,_and_these_specimens_showed_isomorphic_elevation_of_all_five_LD_isoenzymes._Use_of_the_last_of_these_criteria_increased_the_clinical_sensitivity_of_serum_LD-3_elevations_in_active_CGL_from_82%_to_92%._The_mean_serum_LD-3_absolute_value_and_serum_total_LD_activity_usually_showed_statistically_significant_differences_(P_less_than_0.05)_among_patients_with_active_CGL,_those_in_partial_remission,_and_those_in_complete_remission,_but_did_not_distinguish_between_subgroups_of_individuals_with_active_CGL._Elevation_of_the_serum_LD-5/total_LD_ratio_in_16_of_58_patients_was_due_to_hepatic_injury_or_methodologic_imprecision,_showing_analytically_insignificant,_borderline_abnormalities_in_all_cases_of_active_CGL._In_10_of_62_patients_in_complete_remission_or_partial_remission,_however,_such_elevation_was_unexplained._Our_results_indicate_that_the_evaluation_of_serum_LD-3_values_in_both_absolute_and_relative_terms_slightly_increases_the_clinical_sensitivity_of_LD-3,_and,_therefore,_suggest_that_LD-3_might_be_a_useful_marker_for_CGL.